Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo.

The humoral immune response critically relies on the secondary diversification of antibodies. This diversification takes places through somatic remodelling of the antibody genes by two molecular mechanisms, Class Switch Recombination (CSR) and Somatic Hypermutation (SHM). The enzyme Activation Induc...

Full description

Saved in:
Bibliographic Details
Main Authors: Isora V Sernández, Virginia G de Yébenes, Yair Dorsett, Almudena R Ramiro
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0003927&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850183004756901888
author Isora V Sernández
Virginia G de Yébenes
Yair Dorsett
Almudena R Ramiro
author_facet Isora V Sernández
Virginia G de Yébenes
Yair Dorsett
Almudena R Ramiro
author_sort Isora V Sernández
collection DOAJ
description The humoral immune response critically relies on the secondary diversification of antibodies. This diversification takes places through somatic remodelling of the antibody genes by two molecular mechanisms, Class Switch Recombination (CSR) and Somatic Hypermutation (SHM). The enzyme Activation Induced Cytidine Deaminase (AID) initiates both SHM and CSR by deaminating cytosine residues on the DNA of immunoglobulin genes. While crucial for immunity, AID-catalysed deamination is also the triggering event for the generation of lymphomagenic chromosome translocations. To address whether restricting the levels of AID expression in vivo contributes to the regulation of its function, we analysed mice harbouring a single copy of the AID gene (AID(+/-)). AID(+/-) mice express roughly 50% of normal AID levels, and display a mild hyperplasia, reminiscent of AID deficient mice and humans. Moreover, we found that AID(+/-) cells have an impaired competence for CSR and SHM, which indicates that AID gene dose is limiting for its physiologic function. We next evaluated the impact of AID reduction in AID(+/-) mice on the generation of chromosome translocations. Our results show that the frequency of AID-promoted c-myc/IgH translocations is reduced in AID(+/-) mice, both in vivo and in vitro. Therefore, AID is haploinsufficient for antibody diversification and chromosome translocations. These findings suggest that limiting the physiologic levels of AID expression can be a regulatory mechanism that ensures an optimal balance between immune proficiency and genome integrity.
format Article
id doaj-art-5edb5dda04a4474295dba5da62a3db5c
institution OA Journals
issn 1932-6203
language English
publishDate 2008-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-5edb5dda04a4474295dba5da62a3db5c2025-08-20T02:17:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032008-01-01312e392710.1371/journal.pone.0003927Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo.Isora V SernándezVirginia G de YébenesYair DorsettAlmudena R RamiroThe humoral immune response critically relies on the secondary diversification of antibodies. This diversification takes places through somatic remodelling of the antibody genes by two molecular mechanisms, Class Switch Recombination (CSR) and Somatic Hypermutation (SHM). The enzyme Activation Induced Cytidine Deaminase (AID) initiates both SHM and CSR by deaminating cytosine residues on the DNA of immunoglobulin genes. While crucial for immunity, AID-catalysed deamination is also the triggering event for the generation of lymphomagenic chromosome translocations. To address whether restricting the levels of AID expression in vivo contributes to the regulation of its function, we analysed mice harbouring a single copy of the AID gene (AID(+/-)). AID(+/-) mice express roughly 50% of normal AID levels, and display a mild hyperplasia, reminiscent of AID deficient mice and humans. Moreover, we found that AID(+/-) cells have an impaired competence for CSR and SHM, which indicates that AID gene dose is limiting for its physiologic function. We next evaluated the impact of AID reduction in AID(+/-) mice on the generation of chromosome translocations. Our results show that the frequency of AID-promoted c-myc/IgH translocations is reduced in AID(+/-) mice, both in vivo and in vitro. Therefore, AID is haploinsufficient for antibody diversification and chromosome translocations. These findings suggest that limiting the physiologic levels of AID expression can be a regulatory mechanism that ensures an optimal balance between immune proficiency and genome integrity.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0003927&type=printable
spellingShingle Isora V Sernández
Virginia G de Yébenes
Yair Dorsett
Almudena R Ramiro
Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo.
PLoS ONE
title Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo.
title_full Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo.
title_fullStr Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo.
title_full_unstemmed Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo.
title_short Haploinsufficiency of activation-induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo.
title_sort haploinsufficiency of activation induced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0003927&type=printable
work_keys_str_mv AT isoravsernandez haploinsufficiencyofactivationinduceddeaminaseforantibodydiversificationandchromosometranslocationsbothinvitroandinvivo
AT virginiagdeyebenes haploinsufficiencyofactivationinduceddeaminaseforantibodydiversificationandchromosometranslocationsbothinvitroandinvivo
AT yairdorsett haploinsufficiencyofactivationinduceddeaminaseforantibodydiversificationandchromosometranslocationsbothinvitroandinvivo
AT almudenarramiro haploinsufficiencyofactivationinduceddeaminaseforantibodydiversificationandchromosometranslocationsbothinvitroandinvivo